运动导致炎症性肠道疾病的儿童更好地睡眠
Ivana Trivić Mažuranić1, Sara Sila1, Zrinjka Mišak1,2
1Referral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, Zagreb, Croatia.
对患有炎症性肠病 (IBD) 的儿童进行为期6个月的运动计划显著改善了睡眠质量,但并没有显著提高与健康有关的生活质量 (HRQoL). 这项研究强调了运动对儿科IBD患者的好处.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 运动科学运动科学
- 生活质量研究生活质量研究
背景情况:
- 患有炎症性肠道疾病 (IBD) 的儿童经常经历与健康相关的生活质量 (HRQoL) 和睡眠障碍的损害.
- 儿科IBD的缓解并不总是恢复最佳的身体功能或福祉.
研究的目的:
- 研究6个月的家庭炼计划对儿科IBD患者缓解期的HRQoL和睡眠质量的影响.
- 客观地评估干预前后的身体活动水平.
主要方法:
- 42名儿科IBD患者 (平均年龄15.3岁,25名男孩;22名克罗恩氏病,18名性结肠炎) 完成了为期6个月的家庭炼计划.
- 与健康相关的生活质量 (HRQoL) 用IMPACT III问卷进行了测量.
- 使用匹兹堡睡眠质量指数 (PSQI) 评估睡眠质量,使用加速度计客观测量体力活动 (PA).
主要成果:
- 干预后没有观察到HRQoL得分 (IMPACT III) 的统计学上显著改善 (p=0.106).
- 睡眠质量受损 (PSQI > 5) 的患病率显著下降,从30.9%降至23.8% (p=0.027).
- 基线轻体活动 (LPA) 与HRQoL (p=0.013) 有积极的相关性. 干预后,HRQoL的变化与中度至强度的PA (MVPA) (p=0.047) 呈正相关,与PSQI得分的变化呈负相关 (p=0.001).
结论:
- 一个为期6个月的家庭抵抗训练计划显著减少了儿科IBD患者的睡眠质量受损的缓解.
- 虽然HRQoL的改善没有达到统计学意义,但相关性表明增加的身体活动和更好的HRQoL和睡眠结果之间存在联系.
更多相关视频
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
08:20Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood
Published on: October 2, 2019
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
